NYSEEnergyOil & Gas Equipment & ServicesS&P SmallCap 600
$25.32
+0.19 (+0.76%)
Close of Nov 09, 2026 · end-of-day data
INVX 8-K filings in 2026
Every material Form 8-K Innovex International filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Innovex International reported third-quarter 2026 revenue of $265 million, up 10% from a year earlier, and Adjusted EBITDA of $55 million, up from $44 million. Net income fell to $26 million from $39 million a year earlier, and diluted EPS was $0.37 versus $0.57, so shareholders see higher sales alongside lower GAAP profit. The company also guided fourth-quarter 2026 revenue to $260 million to $270 million and Adjusted EBITDA to $53 million to $58 million.
Q3 2026 revenue was $265 million, up 8% from Q2 2026 and up 10% from Q3 2025.
Net income was $26 million versus $39 million in Q3 2025; diluted EPS was $0.37 versus $0.57.
Income from operations was $32 million, down from $62 million a year earlier.
Q4 2026 guidance: revenue of $260 million to $270 million and Adjusted EBITDA of $53 million to $58 million.
Innovex International entered an underwriting agreement with Amberjack Capital Partners affiliates and Barclays Capital for the sale of 5,000,000 common shares by the selling stockholders. The company sold no shares and received no proceeds, so the offering does not add new shares or cash to the company.
Selling stockholders are affiliates of Amberjack Capital Partners, L.P.; the company received no proceeds
5,000,000 shares offered at a price to the underwriter of $28.71 per share
Underwriting agreement dated August 6, 2026; offering closed August 10, 2026
Offering made under an effective Form S-3 shelf registration (File No. 333-282178)
Innovex reported second-quarter 2026 revenue of $245 million, up 9% from a year earlier, and net income of $25 million, or $0.36 per diluted share, after a net loss in the first quarter tied to a $48.8 million legal settlement provision. The company also gave third-quarter guidance of $260 to $270 million in revenue and $51 to $57 million in Adjusted EBITDA, which includes TCO, a business it acquired on July 1, 2026 for $95 million in cash and stock.
Q2 2026 revenue was $244.9 million, up 2% from Q1 2026 and up 9% from Q2 2025.
Net income was $25.0 million ($0.36 per diluted share), compared with a net loss of $16.7 million in Q1 2026 and net income of $15.3 million in Q2 2025.
Adjusted EBITDA was $48.0 million, down from $49.3 million in Q1 2026 and up from $46.6 million in Q2 2025.
Cash and cash equivalents were $222 million at June 30, 2026, with no bank debt; free cash flow was $30.4 million.
Innovex reported first-quarter 2026 revenue of $239.0 million, down 13% from the prior quarter and 1% from a year earlier, and a GAAP net loss of $16.7 million, compared with net income of $14.8 million a year earlier. The loss reflects a $48.8 million provision for a legal settlement tied to the Impulse Litigation, while non-GAAP Adjusted EBITDA rose to $49.3 million, and the company guided second-quarter 2026 Adjusted EBITDA to $43 million to $48 million.
Revenue of $239.0 million, down from $273.6 million in the fourth quarter of 2025 and $240.4 million in the first quarter of 2025
Net loss of $16.7 million, or $0.24 per share, including a $48.8 million provision for legal settlement, versus net income of $14.8 million, or $0.21 per share, a year earlier
Adjusted EBITDA (non-GAAP) of $49.3 million with a 21% margin, compared with $45.9 million and 19% a year earlier
Second-quarter 2026 guidance: revenue of $235 million to $245 million and Adjusted EBITDA of $43 million to $48 million
Innovex International entered a February 25, 2026 underwriting agreement under which affiliates of Amberjack Capital Partners sold 5,750,000 shares at $25.75 each, and the underwriters later exercised their option in full for 862,500 more. Innovex sold no shares and received no offering proceeds, but it bought 575,000 shares from the underwriters for about $14.1 million under its existing buyback program, leaving about $76.6 million remaining under that program.
Selling stockholders sold 5,750,000 shares at $25.75 per share; underwriters exercised a 30-day option for 862,500 additional shares on February 26, 2026
Innovex did not sell any shares and received no proceeds from the offering
Innovex repurchased 575,000 shares for approximately $14.1 million; about $76.6 million remains under the buyback program
Offering and share repurchase closed on February 27, 2026
Innovex reported fourth-quarter 2025 revenue of $274 million, up 14% from the prior quarter, but net income fell to $14 million from $39 million in the third quarter and $32 million a year earlier. The company guided first-quarter 2026 revenue to $225 million to $235 million and Adjusted EBITDA to $38 million to $42 million, both below its fourth-quarter results, citing lower subsea deliveries and seasonality.
Q4 2025 revenue of $274 million, up from $240 million in Q3 2025 and $251 million in Q4 2024
Q4 2025 net income of $14 million (5% margin) and diluted EPS of $0.20, versus $0.57 in Q3 2025
Q4 2025 Adjusted EBITDA of $52 million (19% margin); full-year 2025 free cash flow of $156 million
Q1 2026 guidance: revenue of $225 million to $235 million and Adjusted EBITDA of $38 million to $42 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Innovex International filing is on SEC EDGAR ↗. 8-K briefs of other companies →